Abstract
Background: Data on the prevalence of sleep-disordered breathing (SDB) in people with HIV are limited. Moreover, whether the associations between SDB and age or BMI differ by HIV status is unknown. Research Question: Is SDB more prevalent in men with HIV than those without HIV, and do the predictors of SDB differ between the two groups? Study Design and Methods: Home polysomnography was used in the Multicenter AIDS Cohort Study to assess SDB prevalence in men with (n = 466; 92% virologically suppressed) and without (n = 370) HIV. SDB was defined using the oxygen desaturation index (ODI) and the apnea-hypopnea index (AHI), using four definitions: ≥ 5 events/h based on an ODI with a 3% (ODI3) or 4% (ODI4) oxygen desaturation, or an AHI with a 3% oxygen desaturation or EEG arousal (AHI3a) or with a 4% oxygen desaturation (AHI4). Results: SDB prevalence was similar in men with and without HIV using the ODI3 and AHI3a definitions. However, SDB prevalence was higher in men with than without HIV using the ODI4 (55.9% vs 47.8%; P = .04) and the AHI4 definitions (57.9% vs 50.4%; P = .06). Mild and moderate SDB were more common in men with than without HIV. Associations between SDB prevalence and age, race, and BMI were similar in men with and without HIV. Among men with HIV, viral load, CD4 cell count, and use of antiretroviral medications were not associated with SDB prevalence. Interpretation: SDB prevalence was high overall but greater in men with than without HIV using the ODI4 threshold definition. Efforts to diagnose SDB are warranted in people with HIV, given that SDB is associated with daytime sleepiness and impaired quality of life.
Original language | English (US) |
---|---|
Pages (from-to) | 687-696 |
Number of pages | 10 |
Journal | CHEST |
Volume | 163 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2023 |
Funding
The authors have reported to CHEST the following: N. M. P. received research grant support from Philip-Respironics and Resmed for work unrelated to this manuscript; S. R. P. has received research funding through his institution from Bayer Pharmaceuticals, Philips Respironics, Respicardia, and Sommetrics unrelated to this work; and has served as a consultant to Bayer Pharmaceuticals, NovaResp Technologies, Philips Respironics, and Powell Mansfield, Inc. T. T. B. has served as a consultant to ViiV Healthcare , Merck , Gilead Sciences , Janssen, and Theratechnologies. None declared (N. A., V. S., J. J.-J. C., G. D., J. B. M.). Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS), now the MACS/WIHS Combined Cohort Study (MWCCS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). N. M. P. was supported by NIH grants HL146709, HL11716, and HL075078. MWCCS was supported by the following: Baltimore Clinical Research Site (CRS) [Grant U01-HL146201 (T. T. B. and J. B. M.)]; Data Analysis and Coordination Center [Grant U01-HL146193 (G. D., Stephen Gange, and Elizabeth Golub)]; Chicago-Northwestern CRS [Grant U01-HL146242 (Steven Wolinsky)]; Los Angeles CRS [Grant U01-HL146333 (Roger Detels and Matthew Mimiaga)]; Pittsburgh CRS (Jeremy Martinson and Charles Rinaldo). The MWCCS is funded primarily by the National Heart, Lung, and Blood Institute , with additional cofunding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development , the National Institute on Aging , National Institute of Dental and Craniofacial Research , the National Institute of Allergy and Infectious Diseases , the National Institute of Neurological Disorders and Stroke , the National Institute of Mental Health , the National Institute on Drug Abuse , the National Institute of Nursing Research , the National Cancer Institute , the National Institute on Alcohol Abuse and Alcoholism , the National Institute on Deafness and Other Communication Disorders , the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Minority Health and Health Disparities , and in coordination and alignment with the research priorities of the National Institutes of Health , Office of AIDS Research . MWCCS data collection also is supported by Grants UL1-TR003098 ( Johns Hopkins University Institute for Clinical and Translational Research) and UL1-TR001881 ( University of California, Los Angeles , Clinical and Translational Science Institute).
Keywords
- HIV
- prevalence
- sleep apnea
- sleep-disordered breathing
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine
- Pulmonary and Respiratory Medicine